RGC (Regencell Bioscience Holdings) Total Long-Term Assets: $0.66 Mil (As of Dec. 2025)


RGC Regencell Bioscience Holdings Ltd RGC
33 GF Score
Price $5.88
! 2 Warning Signs
View Full Analysis

What is Regencell Bioscience Holdings Total Long-Term Assets?

Regencell Bioscience Holdings RGC -3.13% 33 Total Long-Term Assets is $0.66 Mil as of Dec. 2025. GuruFocus rates RGC with a GF Score™ of 33/100. The stock has 2 warning signs investors should review.

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Regencell Bioscience Holdings's Total Long-Term Assets for the quarter that ended in Dec. 2025 was $0.66 Mil.

Regencell Bioscience Holdings Total Long-Term Assets Related Terms

Regencell Bioscience Holdings Total Long-Term Assets Historical Data

* Premium members only.

The historical data trend for Regencell Bioscience Holdings's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Regencell Bioscience Holdings Total Long-Term Assets Chart

Regencell Bioscience Holdings Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Total Long-Term Assets
Get a 7-Day Free Trial 0.27 1.57 1.00 0.32 0.85

Regencell Bioscience Holdings Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Long-Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.64 0.32 0.89 0.85 0.66
RGC
33GF Score
Regencell Bioscience Holdings Ltd RGC
Total Long-Term Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Regencell Bioscience Holdings Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Frequently Asked Questions Learn more about Total Long-Term Assets →
What does a Total Long-Term Assets of $0.66 Mil mean?
Regencell Bioscience Holdings (RGC) has a Total Long-Term Assets of $0.66 Mil as of Dec. 2025. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on Regencell Bioscience Holdings and its competitors.
Is Regencell Bioscience Holdings' Total Long-Term Assets too high?
Regencell Bioscience Holdings' current Total Long-Term Assets is $0.66 Mil. Overall, Regencell Bioscience Holdings has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Regencell Bioscience Holdings' Total Long-Term Assets compare to SUPN and BCRX?
Regencell Bioscience Holdings' Total Long-Term Assets of $0.66 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Long-Term Assets for a Drug Manufacturers company?
A good Total Long-Term Assets depends on the Drug Manufacturers industry context. However, Total Long-Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Long-Term Assets mean?
A high Total Long-Term Assets can signal that a stock is expensive relative to its fundamentals. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on Regencell Bioscience Holdings and its competitors. Regencell Bioscience Holdings's current Total Long-Term Assets is $0.66 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Regencell Bioscience Holdings stock overvalued right now?
Regencell Bioscience Holdings (RGC) has a current Total Long-Term Assets of $0.66 Mil. The current Total Long-Term Assets is $0.66 Mil. Regencell Bioscience Holdings' overall GF Score™ is 33/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Long-Term Assets calculated?
Total Long-Term Assets is calculated from a company's financial statements. For Regencell Bioscience Holdings (RGC), the current Total Long-Term Assets is $0.66 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Regencell Bioscience Holdings Business Description

Address 29 Leighton Road, 9th Floor, Chinachem Leighton Plaza, Causeway Bay, Hong Kong, HKG
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
33GF Score

Get the complete analysis for RGC

Total Long-Term Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.88
Price